Eye Care

SMILE (Small Incision Lenticule Extraction) is a minimally invasive vision correction procedure that removes a thin disc of corneal tissue through a small incision, without creating a flap. Pricing varies between standard SMILE and the newer SMILE Pro (faster, with robotic centration), with SMILE Pro commanding a premium. Surgeon experience is particularly important for SMILE outcomes, and high-volume surgeons at specialized eye centers may charge more. Pricing is per eye, and the degree of myopia or astigmatism being corrected affects the procedure complexity. China was an early adopter of SMILE technology with some of the world's most experienced SMILE surgeons, offering the procedure at 40–60% less than US or European prices.

Femtosecond LASIK (also called all-laser LASIK) uses a femtosecond laser instead of a mechanical microkeratome to create the corneal flap, followed by excimer laser reshaping for vision correction. Pricing depends on whether a full all-laser platform is used or a hybrid approach, the generation and brand of femtosecond laser (IntraLase, Ziemer, or VisuMax), and the surgeon's experience and clinic reputation. As with standard LASIK, pricing is per eye, and wavefront-optimized or topography-guided profiles add to the cost. China's major eye hospital chains invest heavily in the latest-generation femtosecond platforms, offering this premium procedure at 40–60% below Western pricing with comparable outcomes.

LASIK (Laser-Assisted In Situ Keratomileusis) reshapes the cornea using an excimer laser to correct nearsightedness, farsightedness, and astigmatism. Key pricing factors include the technology used — standard microkeratome LASIK is most affordable, while wavefront-guided or custom LASIK costs more for enhanced precision. Equipment brand (VISX, WaveLight, or Zeiss MEL) and surgeon experience at high-volume centers also affect price. Most clinics price per eye, so bilateral treatment doubles the cost. In China, LASIK is performed at dedicated eye hospitals (like Aier Eye Hospital Group) with the latest equipment at 50–70% less than US pricing, with surgeons who perform thousands of procedures annually.

ICL (Implantable Collamer Lens) is a vision correction procedure where a biocompatible lens is implanted inside the eye, ideal for patients with high myopia or thin corneas who are not LASIK candidates. Price depends on lens type — standard spherical ICL is less expensive, while toric ICL (which also corrects astigmatism) costs more. The degree of myopia affects lens specifications and cost, and pricing is typically per eye. Pre-operative testing, including endothelial cell count and anterior chamber depth measurement, may be bundled or charged separately. China is one of the world's highest-volume markets for ICL surgery, driving competitive pricing at 40–60% below US costs with Visian ICL (STAAR Surgical) lenses.

Cataract surgery removes the clouded natural lens and replaces it with an artificial intraocular lens (IOL) to restore clear vision. The primary pricing factors are surgical technique — standard phacoemulsification is most common and affordable, while femtosecond laser-assisted cataract surgery offers greater precision at higher cost. IOL choice dramatically affects price: basic monofocal lenses are cheapest, while multifocal, extended depth-of-focus (EDOF), or toric IOLs for astigmatism correction cost significantly more. Pricing is per eye, and premium IOLs can add thousands to the base price. China performs more cataract surgeries than any other country, with experienced surgeons and premium IOL options at 50–70% less than US costs.